Core Scientific, Inc. CORZ
11.19 USD -1.57 (-12.34%)
Nov 5, 2026, 12:00 PM EST
10.59 Day range 12.60
11.19 52-week range 29.16
- YTD
- -23.18%
- 1 year
- -48.69%
Financial health
Altman Z-Score
-0.83 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 1
- Return on Equity 5
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -16.5×
FY 2019 5y median -2.7× FY 2025
P/S 14.5×
FY 2019 5y median 2.6× FY 2025
P/B -4.8×
FY 2019 5y median -2.9× FY 2025
P/FCF -10.3×
FY 2019 5y median -6.1× FY 2025
EV/EBITDA -25.9×
FY 2019 5y median -3.4× FY 2025
EV/Sales 16.9×
FY 2019 5y median 4.2× FY 2025
FCF Yield -9.7%
FY 2019 5y median -9.7% FY 2025
Profitability
Gross Margin 11.9%
FY 2019 5y median 23.7% FY 2025
Operating Margin -70.4%
FY 2019 5y median -3.8% FY 2025
Net Margin -90.5%
FY 2019 5y median -90.5% FY 2025
ROE 30.0%
FY 2019 5y median 41.3% FY 2025
ROIC -14.3%
FY 2019 5y median -1.3% FY 2025
ROA -12.3%
FY 2019 5y median -34.6% FY 2025
Growth (YoY)
Revenue -37.5%
FY 2019 FY 2025
Operating Income -1069.8%
FY 2019 FY 2025
EPS (diluted) 82.9%
FY 2019 FY 2025
Free Cash Flow -765.7%
FY 2019 FY 2025
Financial Health
Current Ratio 1.1×
FY 2019 5y median 1.1× FY 2025
Quick Ratio 1.1×
FY 2019 5y median 1.1× FY 2025
Debt / Equity -1.1×
FY 2019 5y median -1.1× FY 2025
Net Debt / EBITDA -3.6×
FY 2019 5y median -0.3× FY 2025
Interest Coverage 0.0×
FY 2019 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31